Research and Development (R&D) in the pharmaceutical industry is a crucial aspect that drives innovation, drug discovery, and ultimately, the development of new medicines and treatments.

This is the initial phase where our researchers identify potential drug candidates. It involves understanding the biology of diseases, identifying molecular targets, and screening compounds for their potential to interact with these targets.In this RACE PHARMA  is expert.

Our clinical research involves testing the compounds in laboratory and animal studies to understand their pharmacokinetics  and toxicology profiles.If a drug  shows promise in preclinical studies, it moves into clinical trials.

Before a new drug can be marketed, it must be approved by regulatory agencies such as the FDA (Food and Drug Administration) in the United States or the EMA (European Medicines Agency) in Europe. These agencies review data from clinical trials to ensure that the benefits of the drug outweigh its risks.

Advances in technology, such as high-throughput screening, computational modeling, and genomic analysis, play a crucial role in accelerating drug discovery and development processes.we are playing major role in new technologies.

RACE Pharmaceutical  collaborate with HALDANE PHARMACEUTICALS IN SINGAPORE.